These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 17617292

  • 1. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM, Smits LJ, Schouten JS, Peeters FP, Prins MH.
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [Abstract] [Full Text] [Related]

  • 2. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 3. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E, Chen PS, Chang HH, Gean PW, Tsai HC, Yang YK, Lu RB.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct 01; 33(7):1167-72. PubMed ID: 19560507
    [Abstract] [Full Text] [Related]

  • 4. Sequence analysis of the serotonin transporter and associations with antidepressant response.
    Kraft JB, Slager SL, McGrath PJ, Hamilton SP.
    Biol Psychiatry; 2005 Sep 01; 58(5):374-81. PubMed ID: 15993855
    [Abstract] [Full Text] [Related]

  • 5. Serotonin transporter gene and response to lithium augmentation in depression.
    Stamm TJ, Adli M, Kirchheiner J, Smolka MN, Kaiser R, Tremblay PB, Bauer M.
    Psychiatr Genet; 2008 Apr 01; 18(2):92-7. PubMed ID: 18349701
    [Abstract] [Full Text] [Related]

  • 6. Anticipated outcomes from introduction of 5-HTTLPR genotyping for depressed patients: an expert Delphi analysis.
    Oestergaard S, Møldrup C.
    Public Health Genomics; 2010 Apr 01; 13(7-8):406-14. PubMed ID: 20606382
    [Abstract] [Full Text] [Related]

  • 7. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E, Tammiste A, Kallassalu K, Eller T, Vasar V, Nutt DJ, Metspalu A.
    Eur Neuropsychopharmacol; 2009 Jun 01; 19(6):451-6. PubMed ID: 19272758
    [Abstract] [Full Text] [Related]

  • 8. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH, Wong ML, Choi MJ, Paik JW, Lee MS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1317-21. PubMed ID: 17618721
    [Abstract] [Full Text] [Related]

  • 9. 5-HTTLPR modulates antidepressant efficacy in depressed women.
    Gressier F, Bouaziz E, Verstuyft C, Hardy P, Becquemont L, Corruble E.
    Psychiatr Genet; 2009 Aug 15; 19(4):195-200. PubMed ID: 19451862
    [Abstract] [Full Text] [Related]

  • 10. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA, Esdaile JM, Anis AH.
    J Rheumatol; 2002 Dec 15; 29(12):2507-12. PubMed ID: 12465143
    [Abstract] [Full Text] [Related]

  • 11. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK.
    JAMA; 2006 Oct 04; 296(13):1609-18. PubMed ID: 17018806
    [Abstract] [Full Text] [Related]

  • 12. Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.
    Popp J, Leucht S, Heres S, Steimer W.
    Pharmacogenomics; 2006 Mar 04; 7(2):159-66. PubMed ID: 16515395
    [Abstract] [Full Text] [Related]

  • 13. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.
    Ferreira Ade A, Neves FS, da Rocha FF, Silva GS, Romano-Silva MA, Miranda DM, De Marco L, Correa H.
    J Affect Disord; 2009 Jan 04; 112(1-3):267-72. PubMed ID: 18534687
    [Abstract] [Full Text] [Related]

  • 14. Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries.
    Olgiati P, Bajo E, Bigelli M, De Ronchi D, Serretti A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan 10; 36(1):147-54. PubMed ID: 21911028
    [Abstract] [Full Text] [Related]

  • 15. A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.
    Serretti A, Olgiati P, Bajo E, Bigelli M, De Ronchi D.
    World J Biol Psychiatry; 2011 Oct 10; 12(7):501-15. PubMed ID: 21595526
    [Abstract] [Full Text] [Related]

  • 16. Neural and genetic correlates of antidepressant response to sleep deprivation: a functional magnetic resonance imaging study of moral valence decision in bipolar depression.
    Benedetti F, Bernasconi A, Blasi V, Cadioli M, Colombo C, Falini A, Lorenzi C, Radaelli D, Scotti G, Smeraldi E.
    Arch Gen Psychiatry; 2007 Feb 10; 64(2):179-87. PubMed ID: 17283285
    [Abstract] [Full Text] [Related]

  • 17. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A, Benedetti F, Zanardi R, Smeraldi E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul 10; 29(6):1074-84. PubMed ID: 15939518
    [Abstract] [Full Text] [Related]

  • 18. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
    Bi Y, Ren D, Guo Z, Ma G, Xu F, Chen Z, An L, Zhang N, Ji L, Yuan F, Liu L, Hou B, Yang F, Yu S, Yi Z, Xu Y, He L, Sun X, Dong Z, Wu S, Zhao L, Cai C, Li X, Yu T, Shi Y, He G.
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan 10; 104():110036. PubMed ID: 32702381
    [Abstract] [Full Text] [Related]

  • 19. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ, Chen TJ, Tsai SJ, Yu YW, Cheng CY, Hong CJ.
    Pharmacogenet Genomics; 2009 Oct 10; 19(10):735-41. PubMed ID: 19741570
    [Abstract] [Full Text] [Related]

  • 20. The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
    Anton SF, Revicki DA.
    Psychopharmacol Bull; 1995 Oct 10; 31(2):249-58. PubMed ID: 7491376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.